HCSG exceeded expectations in Q3 2025, with strong growth in revenue and profitability, aided by ERC-related benefits and solid operational performance across both service segments.

Healthcare Services Group, Inc. reported strong second-quarter results, with revenue increasing by 7.6% year-over-year to $458.5 million, driven by new client wins and higher retention. Despite a significant non-cash charge related to the Genesis HealthCare restructuring, the company's growth plans and cash flow outlook remain robust, leading to an increased 2025 cash flow from operations forecast.

Healthcare Services Group, Inc. reported a strong first quarter for 2025, with revenue increasing by 5.7% over the prior year to $447.7 million. Net income was $17.2 million, and diluted EPS was $0.23. The company also saw a significant increase in cash flow from operations, reaching $27.5 million, or $32.1 million excluding changes in payroll accrual.

HCSG reported a revenue of $437.8 million and a net income of $11.9 million for Q4 2024. The company expects mid-single digit revenue growth in 2025 and Q1 revenue in the range of $440.0 to $450.0 million.

Healthcare Services Group reported Q3 2024 results with revenue of $428.1 million, net income of $14.0 million, and diluted EPS of $0.19. The company reaffirmed its Q4 revenue estimate of $430.0 to $440.0 million and FY 2024 cash flow forecast of $40.0 to $55.0 million.

HCSG reported Q2 2024 revenue of $426.3 million, in line with expectations. Net loss was ($1.8) million, including a $0.22 impact from client restructuring charges. The company is raising Q3 and Q4 revenue estimates and reaffirming its 2024 adjusted cash flow range of $40.0 to $55.0 million.

HCSG reported Q1 2024 results with revenue of $423.4 million, in line with expectations. Net income was $15.3 million, with diluted EPS of $0.21. The company reiterated its 2024 adjusted cash flow forecast of $40.0 to $55.0 million and expects year-over-year revenue growth.

HCSG's Q3 2023 results showed revenue of $411.4 million, with an adjusted revenue of $424.0 million. The company reported a net loss of $5.5 million, but an adjusted net income of $12.5 million. Adjusted diluted EPS increased by 13.3% over Q3 2022. The company also raised its expectations for the second half of 2023 cash flow from operations.

Healthcare Services Group reported Q2 2023 revenue of $418.9 million, GAAP net income of $8.6 million, or $0.12 per basic and diluted common share, and adjusted EBITDA of $26.3 million.

Healthcare Services Group reported Q1 2023 revenue of $417.2 million, GAAP net income of $12.7 million, or $0.17 per basic and diluted common share, and adjusted EBITDA of $27.5 million.

Healthcare Services Group reported Q4 2022 revenue of $424.0 million and net income of $16.2 million, or $0.22 per basic and diluted common share. The company's Board of Directors has suspended the quarterly cash dividend and authorized the repurchase of up to 7.5 million shares of its common stock.

Healthcare Services Group reported Q3 2022 revenue of $414.5 million and net income of $0.3 million. The company faced challenges within the industry and broader economy, but successfully executed its strategy to improve customer partnerships. The company's Board of Directors declared a quarterly cash dividend of $0.215 per common share.

Healthcare Services Group reported Q2 2022 results, with revenue of $424.9 million and earnings per share of $0.09. The quarter was affected by facility exits and a $7 million increase in AR reserves. The company is focused on modifying service agreements to address inflation and aims to exit the year with cost of services at 86%.

Healthcare Services Group reported Q1 2022 results with revenue of $426.8 million and net income of $11.3 million, or $0.15 per basic and diluted common share. The company's Board of Directors declared a quarterly cash dividend of $0.2125 per common share, marking the 75th consecutive increase since 2003.

Healthcare Services Group reported Q4 2021 results with revenue of $420.4 million and net income of $2.1 million, or $0.03 per basic and diluted common share. The company is actively modifying service agreements to adjust for inflation and expects these modifications to be completed throughout the first half of 2022.

Healthcare Services Group reported Q3 2021 results with revenue of $415.6 million and net income of $9.5 million, or $0.13 per basic and diluted common share. The results were impacted by supply chain disruption, labor availability, and inflation.

Healthcare Services Group, Inc. reported Q2 2021 results with revenue of $398.2 million, net income of $9.6 million, and earnings per share of $0.13. The company expects over $50.0 million of annualized revenue growth, or over $12.5 million per quarter, to be reflected in Q3.

Healthcare Services Group reported Q1 2021 results with revenue of $407.8 million and net income of $24.7 million, or $0.33 per basic and diluted common share. The company's Board of Directors declared a quarterly cash dividend of $0.2075 per common share.

Healthcare Services Group, Inc. reported Q4 2020 revenue of $423.2 million and net income of $27.7 million, or $0.37 per basic and diluted common share. The Company's Board of Directors declared a quarterly cash dividend of $0.20625 per common share.

Healthcare Services Group reported Q3 2020 results with revenue of $435.9 million and net income of $27.6 million, or $0.37 per basic and diluted common share. The company's Board of Directors declared a quarterly cash dividend of $0.205 per common share.

Healthcare Services Group reported Q2 2020 results with revenue of $452.0 million and net income of $23.1 million, or $0.31 per share. Cash flow from operations was $79.7 million. The Board of Directors declared a quarterly cash dividend of $0.20375 per common share.

Healthcare Services Group, Inc. reported Q1 2020 results with revenue of $449.2 million, net income of $20.2 million, and EPS of $0.27. The company's Board of Directors declared a quarterly cash dividend of $0.2025 per common share.

Healthcare Services Group reported Q4 2019 revenue of $447.0 million and net income of $18.9 million, or $0.25 per share. The company's Board of Directors declared a quarterly cash dividend of $0.20125 per common share.